Latham & Watkins·FDA / LIFE SCIENCES REGULATORY
CMS Proposes RAPID Pathway to Combine FDA Approval, Medicare Coverage
The proposed RAPID pathway from the Centers for Medicare & Medicaid Services aims to shorten the gap between FDA device approval and Medicare coverage decisions from years to months.
cmsfdamedical-devicesrapid-pathwaymedicareregulatory-pathway
Read the original firm alert → Wednesday, September 23, 2026